Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sagimet Biosciences Inc. | Executive Chairman, Director | Series A Common Stock | 156K | $641K | $4.10 | Nov 17, 2023 | Direct |
Sagimet Biosciences Inc. | Executive Chairman, Director | Series A Common Stock | 119K | $376K | $3.17 | Jul 23, 2024 | Direct |
Sagimet Biosciences Inc. | Executive Chairman, Director | Stock Option (Right to Buy) | 0 | Sep 7, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SGMT | Sagimet Biosciences Inc. | Jul 23, 2024 | 1 | -$74.8K | 4 | Jul 25, 2024 | Executive Chairman, Director |
SGMT | Sagimet Biosciences Inc. | Jul 19, 2024 | 1 | -$43.6K | 4 | Jul 23, 2024 | Executive Chairman, Director |
SGMT | Sagimet Biosciences Inc. | Nov 17, 2023 | 1 | $0 | 4 | Nov 21, 2023 | Executive Chairman, Director |
SGMT | Sagimet Biosciences Inc. | Sep 7, 2023 | 2 | $4.45K | 4 | Sep 8, 2023 | Executive Chairman, Director |
SGMT | Sagimet Biosciences Inc. | Jul 18, 2023 | 16 | $0 | 4 | Jul 20, 2023 | Director |
SGMT | Sagimet Biosciences Inc. | Jul 13, 2023 | 0 | $0 | 3 | Jul 13, 2023 | Director |